Evidence map›Paper›PMID 39130084›Full record

ArticleOpen forum infectious diseases2024

Lower Rates of

Aliya Bryce, Sara Davison, Bart J Currie, Johanna M Birrell, Robert W Baird, Asanga Abeyaratne, Sandawana William Majoni, Teana Brewster-O'Brien, Steven Y C Tong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Analysis of Drug-Resistant Bacteria Seasonality in Japan Using Financial Time Series Analysis Method: A Nationwide Longitudinal Study.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  2. Article
  3. Article
  4. Trimethoprim-Sulfamethoxazole forOpen forum infectious diseases · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aliya BryceDepartment of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.ORCID https://orcid.org/0000-0002-2006-5122
Sara DavisonDepartment of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Bart J CurrieDepartment of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.ORCID https://orcid.org/0000-0002-8878-8837
Johanna M BirrellNorthern Territory Centre for Disease Control, NT Health, Darwin, Northern Territory, Australia.
Robert W BairdDepartment of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Asanga AbeyaratneMenzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Sandawana William MajoniMenzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Teana Brewster-O'BrienDepartment of Nephrology, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Steven Y C TongVictorian Infectious Diseases Service, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-9593-1868

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemodialysis is a risk factor for

Indexed as

antibiotic prophylaxisbloodstream infectionhemodialysisStaphylococcus aureustrimethoprim-sulfamethoxazole

Identifiers

PMID39130084
PMCPMC11310582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.